Update to our US election baskets

Equities 6 minutes to read

Peter Garnry

Head of Equity Strategy

Summary:  The market was yesterday most likely creating a new narrative on a Biden victory which is that of potential clean sweep by the Democrats which could pave the way for the recently House approved $2.2trn stimulus bill. However, we are still not buying the net positive narrative as Biden will most likely hike corporate taxes creating a significant headwind for US earnings and thus we are still leaning towards a Trump victory being more positive for equities. We have updated our election baskets so that a Trump victory is now positive for health care stocks. The updated baskets do also include single stocks.


On Friday we put out our first take on US election baskets as a response to the first US presidential debate. But going back to 20 August we did an extensive list of green energy stocks that could gain on a Biden election win as his Clean Energy Revolution would increase spending and enact policies in favour of green energy stocks.

Our initial take ahead of the US election on 3 November was that Biden would be perceived as net negative for equities due to uncertainty over taxes and in particularly corporate taxes. According to Biden’s campaign details his proposed corporate tax hikes including hiking the GILTI (global intangible low-taxed income) tax rate which would apply mostly to technology and health care companies would be negative for the technology, communications services and health care sectors. This is also long-term the direction under a Biden administration and could create up to 10% headwind for S&P 500 earnings. More details can be found in the soon to be released Q4 Outlook. You can sign up here for Q4 2020 Quarterly Outlook live presentation on Friday.

What we saw yesterday in equity markets was mostly likely a reflation trade (long growth stocks and small caps) but also the market most likely pricing out the scenario for a contested election given Biden is gaining in the polls. Given this lean in polls the market may also be discounting a higher probability for a clean sweep by the Democrats (getting the majority in US Congress), which will make it more likely that the Democrats’ $2.2trn stimulus bill passed in the House (controlled by the Democrats) four days ago could go all the way after the election on a clean sweep victory. That would increase fiscal stimulus at a much-needed time as the US economy still lacks 4% more growth to be back at positive y/y growth. So, the market seems to be switching to a positive Biden win narrative for equities. We are not fully convinced and is thus not updating our election baskets on that account.

However, compared to the US election baskets presented on Friday we have changed two things. We have switched the positive oil & gas theme under a Trump victory to oil & gas exploration as this is a higher beta play on less strict environmental laws under Trump. We have also switched the health care theme under Trump victory from negative to a positive view given the Regeneron Pharmaceuticals story related to its antibody treatment of Trump and potential emergency approval by the FDA. You can read more about this story in our Quick Take and podcast from today. It seems more and more likely that the health care sector will have less FDA regulation under a Trump administration and from a shareholder perspective this could be interpreted positively if Trump wins.

The table is the same US election basket from Friday’s analysis but now updated with single stocks. We have put in the five largest stocks in each category selecting them from key benchmark indices. They are therefore not our direct single stock recommendations but inspiration for which single stocks are attached to each theme under a Biden or Trump victory.

Disclaimer

The Saxo Bank Group entities each provide execution-only service and access to Analysis permitting a person to view and/or use content available on or via the website is not intended to and does not change or expand on this. Such access and use are at all times subject to (i) The Terms of Use; (ii) Full Disclaimer; (iii) The Risk Warning; (iv) the Rules of Engagement and (v) Notices applying to Saxo News & Research and/or its content in addition (where relevant) to the terms governing the use of hyperlinks on the website of a member of the Saxo Bank Group by which access to Saxo News & Research is gained. Such content is therefore provided as no more than information. In particular no advice is intended to be provided or to be relied on as provided nor endorsed by any Saxo Bank Group entity; nor is it to be construed as solicitation or an incentive provided to subscribe for or sell or purchase any financial instrument. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. As such no Saxo Bank Group entity will have or be liable for any losses that you may sustain as a result of any investment decision made in reliance on information which is available on Saxo News & Research or as a result of the use of the Saxo News & Research. Orders given and trades effected are deemed intended to be given or effected for the account of the customer with the Saxo Bank Group entity operating in the jurisdiction in which the customer resides and/or with whom the customer opened and maintains his/her trading account. Saxo News & Research does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Bank Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication under relevant laws.

Please read our disclaimers:
- Notification on Non-Independent Investment Research (https://www.home.saxo/legal/niird/notification)
- Full disclaimer (https://www.home.saxo/en-hk/legal/disclaimer/saxo-disclaimer)

Saxo Capital Markets HK is a company authorised and regulated by the Securities and Futures Commission of Hong Kong. Saxo Capital Markets HK Limited holds a Type 1 Regulated Activity (Dealing in securities); Type 2 Regulated Activity (Dealing in Futures Contract) and Type 3 Regulated Activity (Leveraged foreign exchange trading) licenses (CE No. AVD061). Registered address: 19th Floor, Shanghai Commercial Bank Tower, 12 Queen’s Road Central, Hong Kong

By clicking on certain links on this site, you are aware and agree to leave the website of Saxo Capital Markets, proceed on to the linked site managed by Saxo Group and where you will be subject to the terms of that linked site.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the US and other countries. AppStore is a service mark of Apple Inc.

Please note that the information on this site and any product and services we offer are not targeted at investors residing in the United States and Japan, and are not intended for distribution to, or use by any person in any country or jurisdiction where such distribution or use would be contrary to local law or regulation. Please click here to view our full disclaimer.